focus
Previous article:
Medicare details structure of new drug price negotiation program
Next article: The problems with dementia villages
Next article: The problems with dementia villages
hotspot
hotspot
-
Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
2025-08-19 14:47 -
CDC backtracks, saying fully vaccinated people can go maskless indoors
2025-08-19 14:17 -
Roche acquires Telavant from Roivant, adding experimental IBD treatment
2025-08-19 14:16 -
J&J lung cancer data amount to new salvo against AstraZeneca
2025-08-19 12:51 -
FDA clears Verve to begin U.S. study of gene
2025-08-19 12:48 -
Health tech investors get more selective as pandemic boom fades
2025-08-19 12:21